Complete genomics inc (GNOM)
Balance Sheet / Quarterly
Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Cash and cash equivalents

34,715

39,258

47,120

77,074

64,911

82,757

68,918

Short-term investments

-

4,000

15,998

6,000

40,202

43,657

-

Accounts receivable

5,388

7,139

5,979

6,488

4,941

7,263

4,943

Inventory

6,764

7,628

6,900

4,121

3,268

4,290

3,980

Prepaid expenses

1,333

1,663

1,708

1,141

810

775

1,101

Other current assets

95

77

153

341

359

73

78

Total current assets

48,295

59,765

77,858

95,165

114,491

138,815

79,020

Property and equipment, net

31,393

34,222

34,001

33,592

31,815

28,650

23,843

Other assets

1,132

1,196

1,415

1,446

890

900

297

Total assets

80,820

95,183

113,274

130,203

147,196

168,365

103,160

Accounts payable

4,974

6,493

4,215

5,363

5,200

6,283

3,066

Accrued liabilities

5,980

5,806

7,187

5,400

5,137

4,382

3,102

Notes payable, current

19,436

21,608

22,939

7,099

5,157

3,262

5,780

Convertible notes payable

6,000

-

-

-

-

-

-

Deferred revenue

9,089

9,783

11,159

10,026

6,929

7,077

5,739

Total current liabilities

45,479

43,690

45,500

27,888

22,423

21,004

17,687

Notes payable, net of current

-

-

-

16,162

18,411

20,598

7,521

Deferred rent, net of current

2,899

3,117

3,334

3,539

3,736

3,935

4,316

Total liabilities

48,378

46,807

48,834

47,589

44,570

45,537

29,524

Commitments and contingencies (Note 8)

0

0

0

0

0

0

0

Preferred stock, par value $0.001 - 5,000,000 shares authorized and no shares outstanding at September 30, 2012 and December 31, 2011

0

0

0

0

-

-

0

Preferred stock, par value $0.001-5,000,000 shares authorized and no shares issued and outstanding at September 30, 2011 and December 31, 2010

-

-

-

-

0

0

-

Common stock, $0.001 par value-300,000,000 shares authorized and 34,457,289 shares issued and outstanding at September 30, 2012; 300,000,000 shares authorized and 33,409,638 shares issued and outstanding at December 31, 2011

34

34

34

33

33

33

26

Additional paid-in capital

300,652

298,597

295,834

293,777

291,467

290,062

212,458

Accumulated deficit

-268,244

-250,255

-231,428

-211,196

-188,874

-167,267

-138,848

Total stockholders' equity

32,442

48,376

64,440

82,614

102,626

122,828

73,636

Total liabilities and stockholders' equity

80,820

95,183

113,274

130,203

147,196

168,365

103,160